| Name | Title | Contact Details |
|---|---|---|
Tim Czadzeck |
Director of Information Systems | Profile |
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
JELD-WEN is a leading global designer, manufacturer and distributor of high-performance interior and exterior doors, windows, and related building products serving the new construction and repair and remodeling sectors. Headquartered in Charlotte, N.C., the company operates facilities in 16 countries in North America and Europe and employs approximately 18,000 people. Since 1960, the JELD-WEN team has been committed to making quality products that create safe and sustainable environments for customers, associates and local communities. The JELD-WEN family of brands includes JELD-WEN® worldwide, LaCantina™ and VPI™ in North America, and Swedoor® and DANA® in Europe. For more information about JELD-WEN or to join our team, visit https://www.corporate.jeld-wen.com/.
STARK Group is a leading provider of building materials and services for the construction industry in Europe. Founded in 1896 and headquartered in Frederiksberg, Denmark, the company operates over 1,100 branches and distribution centers across Europe, employing around 19,000 people. STARK Group specializes in the distribution and retail of building materials to professional builders and contractors. They offer product knowledge and advice to help customers select the right materials for their projects. The company also provides efficient logistics solutions to ensure timely delivery of products to construction sites. Their extensive product portfolio includes a wide range of heavy construction materials tailored to meet the diverse needs of the construction sector. STARK Group is committed to sustainability, investing in environmentally friendly facilities and aiming for low-emission classifications in their operations.
Founded in 1996, Swarts, Manning & Associates has quickly established itself as a leader in the insurance industry. As a full-service agency, Swarts, Manning & Associates is dedicated to providing the most comprehensive, customized, and cost-effective insurance solutions available. With specialized departments dedicated to customizing protection for your business, you will partner with an industry expert to assist with your unique risk management needs. Our dedication to customer service and our knowledgeable, friendly staff are just a few of the reasons why Swarts, Manning & Associates stands as a leader and innovator within the insurance industry.